# Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment

> **NCT06951932** · NA · RECRUITING · sponsor: **Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria** · enrollment: 120 (estimated)

## Conditions studied

- Mild Cognitive Impairment (MCI)

## Interventions

- **DIETARY_SUPPLEMENT:** Mediterranean-type diet with MCT supplementation
- **OTHER:** Mediterranean-type food regimen using extra virgin olive oil

## Key facts

- **NCT ID:** NCT06951932
- **Lead sponsor:** Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-03
- **Primary completion:** 2025-07-03
- **Final completion:** 2025-11-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951932, "Evaluation of the Impact of Medium-chain Fatty Acids in the Evolution of Newly Diagnosed Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06951932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*